Sex steroids, lipids, and lipoprotein cholesterols in women with subclinical and overt hypothyroidism before and after L-thyroxine therapy

Clinica Chimica Acta

Volumn 275, Issue 1, 1998, Pages 81-91

  Paoli, Mariela ^a   Bellabarba, Gabriela ^b   Velazquez, Elsy ^a   Mendoza, Soaira ^a   Molina, Carmen ^b   Wang, Ping ^c   Glueck, C J ^c  

^a Hospital Universitario de Los Andes   (Venezuela)

^b UNIVERSIDAD DE LOS ANDES   (Venezuela)

^c JEWISH HOSPITAL   (United States)

Author keywords

L Thyroxine therapy; Lipids; Lipoproteins; Overt hypothyroidism; Sex steroids; Subclinical hypothyroidism

Indexed keywords

ANDROGEN; APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTIRELIN; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; THYRAX; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HYPOTHYROIDISM; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; PRIORITY JOURNAL;

ADULT; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; GONADAL STEROID HORMONES; HUMANS; HYPOTHYROIDISM; REGRESSION ANALYSIS; THYROXINE; TRIGLYCERIDES;

EID: 17544387917     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(98)00074-6     Document Type: Article

References (35)

1. [1] Glueck CJ, Lang J, Tracy T, et al. The common finding of covert hypothyroidism at initial clinical evaluation for hyperlipoproteinemia. Clin Chim Acta 1991;201:113-22.
2. [2] Arem R, Patsch W. Lipoprotein and apolipoprotein levels in subclinical hypothyroidism. Arch Int Med 1990;150:2097-100.
3. [3] Series JJ, Biggart EM, O'Reilly DStJ, et al. The relationship between serum cholesterol and serum thyrotropin, thyroxine, and triiodothyronine concentrations in suspected hypothyroidism. Ann Clin Biochem 1990;27:11-113.
4. [4] Wallace RB, Pomrehn P, Hess G et al. Alterations in clinical chemistry levels associated with dyslipoproteinemias. Circulation 1986;73(Suppl 1):I62-I70.
5. [5] Walton KW, Scott PJ, Dykes PW, et al. The significance of alterations in serum lipids in thyroid dysfunction. Clin Sci 1965;29:217-38.
6. [6] Kuusi T, Taskinen MR, Nikkila EA. Lipoproteins, lipolytic enzymes, and hormonal status in hypothyroid women at different levels of substitution. J Clin Endocrinol Metab 1988;66:51-6.
7. [7] Althaus B, Satub J, Ryff-De Leche A, et al. LDL/HDL changes in subclinical hypothyroidism: possible risk factors for coronary heart disease. Clin Endocrinol 1988;28:157-63.
8. [8] Longcope C, Abend S, Braverman L, et al. Androstenedione and estrone dynamics in hypothyroidism women. J Clin Endocrinol Metab 1990;70:903-7.
9. [9] Beck-Peccoz P, Roncoroni R, Mariotti S, et al. Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (IST): evidence against selective pituitary thyroid hormone resistance in non-neoplastic IST. J Clin Endocrinol Metab 1990;7:19-25.
10. [10] Weinberg R. Lipoprotein metabolism: hormonal regulation. Hosp Pract 1987;15:223-43.
11. [11] Hammond CH, Maxson W. Estrogen replacement therapy. Clin Obstet Gynecol 1986;29:418-30.
12. [12] Bethune J. Interpretation of thyroid function tests. Year Book Medical Publishers 1989;35:541-96.
13. [13] Ishikawa T, Brazier J, Steiner P, et al. A study of the heparin-manganese chloride methods for determination of plasma alpha-lipoprotein cholesterol concentration. Lipids 1976;11:628-39.
14. [14] Friedewald W, Levy R, Frederickson D. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-515.
15. [15] Fox R, Corrigan E, Thomas P, et al. The diagnosis of polycystic ovaries in women with oligo-amenorrhoea: predictive power of endocrine tests. Clin Endocrinol 1991;34:127-31.
16. [16] ILIB Latinoamérica. Recomendaciones de ILIB para el diagnóstico de lasdislipidemias en Latinoamérica. Avances Cardiolögicos, XIV. Suppl. 1, 1994:6-22.
17. [17] Snedecor GW, Cochran WG. Statistical Methods. Ed 7. Ames, IA: Iowa State University Press, 1980.
18. [18] Bell G, Todd W, Forfar J, et al. End-organ responses to thyroxine therapy in subclinical hypothyroidism. Clin Endocrinol 1985;22:83-9.
19. [19] Staels B, Van Tol A, Chan L, et al. Alterations in thyroid status modulate apolipoprotein, hepatic triglyceride lipase, and low density lipoprotein receptor in rats. Endocrinology 1990;127:1144-52.
20. [20] Packard C, Shepherd J, Lindsay G, et al. Thyroid replacement therapy and its influence on post-heparin plasma upases and apolipoprotein-B metabolism in hypothyroidism. J Clin Endocrinol Metab 1993;76:1209-16.
21. [21] Bruin T, Barlingen H, Lindesibenius Trip M, et al. Lipoprotein (a) and apolipoprotein B plasma concentrations in hypothyroid, euthyroid, and hyperthyroid subjects. J Clin Endocrinol Metab 1993;76:121-6.
22. [22] Franklyn J, Daykin J, Betteridge J, et al. Thyroxine replacement therapy and circulating lipid concentrations. Clin Endocrinol 1993;38:453-9.
23. [23] Dean J, Fowler P. Exaggerated responsiveness to thyrotropin releasing hormone: a risk factor in women with coronary artery disease. Br Med J 1985;290:1555-61.
24. [24] Lithell H, Boberg J, Hellsing K, et al. Serum lipoprotein and apolipoprotein concentrations and tissue lipoprotein-lipase activity in overt and subclinical hypothyroidism: the effect of substitution therapy. Eur J Clin Invest 1981;11:3-10.
25. [25] Bogner U, Arntz H, Peters H, et al. Subclinical hypothyroidism and hyperlipoproteinaemia: indiscriminate L-thyroxine treatment not justified. Acta Endocrinol 1993;128:202-6.
26. [26] Caron C, Parra H, Hoff M, et al. Decreased HDL-cholesterol in subclinical hypothyroidism: the effect of L-thyroxine therapy. Clin Endocrinol 1990;33:519-24.
27. [27] Heimberg M, Olubadewo J, Wilcox H. Plasma lipoproteins and regulation of hepatic metabolism of fatty acids in altered thyroid states. Endocr Rev 1985;6:590-607.
28. [28] Raggatt L, Blok R, Hamblin S, et al. Effects of thyroid hormone on sex hormone-binding globulin gene expression in human cells. J Clin Endocrinol Metab 1992;75:116-20.
29. [29] Barlow J, Crowe T, Crowen N, et al. Stimulation of sex hormone-binding globulin mRNA and attenuation of corticosteroid-binding globulin mRNA by triiodothyronine in human hepatoma cells. Eur J Endocrinol 1994;130:166-70.
30. [30] Sorva R, Kuusi T, Dunkel L, et al. Effects of endogenous sex steroids on serum lipoproteins and post-heparin plasma lipolytic enzymes. J Clin Endocrinol Metab 1988;66:408-13.
31. [31] St-Amand J, Despres S, Lemieux B, et al. Does lipoprotein or hepatic lipase activity explain the protective lipoprotein profile of premenopausal women?. Metabolism 1995;44:491-8.
32. 2: relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. J Clin Invest 1987;80:341-7.
33. [33] Tikkanen M, Nikkila E. Regulation of hepatic lipase and serum lipoproteins by sex steroids. Am Heart J 1987;113:562-7.
34. [34] Rapoport B. Pathophysiology of Hashimoto's thyroiditis and hypothyroidism. Annu Rev Med 1991;42:91-6.
35. [35] Wolfe L. Subclinical hypothyroidism. South Med J 1989;82:679-80.